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INHIBITION OF INSULIN AMYLOID FORMATION BY SMALL ORGANOFLUORINE 
MOLECULES 
 
Yanique Thomas, William Horton, Chris D. Tran, Clifford J. Ellstrom, Béla Török, Marianna 
Török 
Department of Chemistry, University of Massachusetts Boston 
 
Many human diseases, including Alzheimer’s disease (AD) and diabetes mellitus type II (DM) 
have been connected to protein misfolding and the formation of highly ordered fibrillar protein 
aggregates called amyloids. DM is characterized by an overproduction of insulin to the point of 
insulin resistance in the body. The protein deposits in the AD-affected brain is related to the 
aggregation of tau protein and amyloid β (Aβ) peptide. Amyloid fibrils and their oligomeric 
precursors are known to be cytotoxic inducing neurological cell death. Recent clinical studies 
have suggested a link between Alzheimer’s disease and DM based on the fact that DM patients 
have double the risk of developing Alzheimer’s disease. It is believed that the increased risk of 
heart disease and stroke linked to DM causes further damage to blood vessels that eventually 
target the brain. Due to the continued rise of both diseases among aging adults, there is 
considerable interest in eluciditating the similarities and differences in the mechanism of amyloid 
formation of insulin and Aβ and understanding how the oligomeric state of  the two peptides 
affect each other’s aggregation and role. Our group has already designed and experimentally 
tested a broad variety of small molecules, including organofluorines that effectively inhibit the 
self-assembly of Aβ. As an extension of these earlier studies the same group of organofluorine 
molecules are being tested for their inhibitory activity in the formation of insulin fibrils. The 
aggregation of insulin with/without these potential inhibitors at 37°C and pH=7.4 are followed by 
a kinetic Thioflavin T (ThT) fluorescence assay and visualized by Atomic Force Microscopy 
(AFM). The small molecule-insulin interactions are also investigated by electrospray mass 
spectrometry (HR-ESI-MS).  
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